Delivery Order SPE2DB24D2010-SPE2DB26FZRZ3
Award Date 10/23/25
Potential Completion Date 10/24/25
Potential Value $37K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $11.9K delivery order to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/mL ampul 2.5mL pharmaceutical product, with an ultimate completion date of July 28, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $2,599.62 delivery order to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/ml ampules (2.5 ml) on September 9, 2025, with completion expected by September 10, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a single delivery order against AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,356.71 to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/ml ampule 2.5ml pharmaceutical supplies. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 18, 2025, issued on September 17, 2025. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $9.68K delivery order to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/mL ampules (2.5 mL units) on July 23, 2025, with completion expected by July 24, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99M vehicle extending through...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Pulmozyme 1 mg/ml ampules (2.5 ml units) with a ceiling value of $12,701.74. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 27, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under the company's larger...
- The Defense Logistics Agency has awarded a delivery order valued at $18,388.41 to AmerisourceBergen Drug Corp for the supply of Pulmozyme 1 mg/ml ampules (2.5 ml vials). This firm fixed-price, non-set-aside delivery order was awarded on May 8, 2025, with an ultimate completion date of May 9, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location. This award represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Pulmozyme 1 mg/ml ampul 2.5ml pharmaceutical product, with a ceiling value of $8,168.13 under a firm fixed-price contract type. This delivery order represents a non-set-aside award issued to the vendor's Conshohocken, Pennsylvania location and is scheduled for ultimate completion by October 22, 2025. The contract is a child award under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/mL ampul 2.5mL, a pharmaceutical product used in treating cystic fibrosis. This firm fixed-price delivery order, valued at $48,360.96, was competitively awarded without set-aside designation and carries an ultimate completion date of October 22, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Pulmozyme 1 mg/mL ampul 2.5mL with a ceiling value of $4,280.40. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and is scheduled for ultimate completion on May 21, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/ml ampules (2.5 ml units) with a contract ceiling value of $2,583.60. The award was made on September 17, 2025, with an ultimate completion date of September 18, 2025, utilizing firm fixed-price pricing with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...